Key result
PDA occluder achieves complete occlusion and 100% survival at one year in a porcine model.
Why the study?
This study evaluated the safety and performance of a developed patent ductus arteriosus occluder device in an animal model.
Does a newly developed patent ductus arteriosus occluder device safely and effectively occlude the target artery in a porcine model?
Does a newly developed patent ductus arteriosus occluder device safely and effectively occlude the target artery in a porcine model?
A newly developed PDA occluder device demonstrated safety, effective occlusion, and good endothelialization up to 1 year in a porcine model, supporting its potential for future human clinical applications.
Supports preclinical PDA occluder safety; leaves open clinical translation pending human trials.
This study assessed the safety and performance of a patent ductus arteriosus (PDA) occluder using a porcine carotid artery model involving three male pigs. Each pig underwent a thorough physical examination and met the criteria for stable health and body weight. On day 0, the occluder was implanted under proper analgesia and anesthesia, with heparin used to prevent clot formation. The deployment process was meticulously evaluated through angiography and Quantitative Vascular Analysis (QVA) before and after implantation. Arteries were harvested at 90, 180, and 365 days for histopathological analysis. The occluder fulfilled all acceptance criteria, demonstrating successful deployment, trackability, and no cranial artery flow above the device. Gross necropsy showed a bulged carotid artery, suggesting a reaction to the device, while histopathological evaluations showed good endothelialization at all time points. The occluder was well-visualized during imaging, deployed easily, and could be withdrawn without issue. It effectively occluded the artery at all follow-ups without migrating from the target site. All animals survived the procedure and post- procedural period with the device intact. These results suggest that the PDA occluder is safe and effective in this model, showing promise for future human clinical applications, though further studies are needed to confirm long-term safety and efficacy.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2024) studied Patent ductus arteriosus (porcine model) (n=3). Patent Ductus Arteriosus (PDA) Occluder Device was evaluated on Proper deployment of the occluder, animal survival, and device performance over time. The Patent Ductus Arteriosus occluder device achieved complete arterial occlusion and 100% animal survival without device migration over a 365-day follow-up in a porcine model.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: